key: cord-0820981-23oewalf
authors: Villena-Tejada, M.; Vera-Ferchau, I.; Cardona-Rivero, A.; Zamalloa-Cornejo, R.; Quispe-Florez, M. M.; Frisancho-Triveno, Z.; Abarca-Melendez, R. C.; Alvarez-Sucari, S. G.; Mejia, C. R.; Yanez, J. A.
title: Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey
date: 2021-05-30
journal: nan
DOI: 10.1101/2021.05.26.21257890
sha: e2efb216010682d75482bb0c305b547b65113b54
doc_id: 820981
cord_uid: 23oewalf

Background: The burden of the COVID-19 pandemic in Peru has led to people seeking alternative treatments as preventives and treatment options such as medicinal plants. This study aimed to assess factors associated with the use of medicinal plants as preventive or treatment of respiratory symptom related to COVID-19 during the pandemic in Cusco, Peru. Method: A web-based cross-sectional study was conducted on general public (20- to 70-year-old) from August 31 to September 20, 2020. Data were collected using a structured questionnaire via Google Forms, it consisted of an 11-item questionnaire that was developed and validated by expert judgment using Aiken's V (Aiken's V > 0.9). Both descriptive statistics and bivariate followed by multivariable logistic regression analyses were conducted to assess factors associated with the use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic. Prevalence ratios (PR) with 95% Confidence Interval (CI), and a P-value of 0.05 was used to determine statistical significance. Results: A total of 1,747 respondents participated in the study, 80.2% reported that they used medicinal plants as preventives, while 71% reported that they used them to treat respiratory symptoms. At least, 24% of respondents used medicinal plants when presenting with two or more respiratory symptoms, while at least 11% used plants for malaise. For treatment or prevention, the multivariate analysis showed that most respondents used eucalyptus (p < 0.001 for both), ginger (p < 0.022 for both), spiked pepper (p < 0.003 for both), garlic (p = 0.023 for prevention), and chamomile (p = 0.011 for treatment). The respondents with COVID-19 (p < 0.001), at older ages (p = 0.046), and with a family member or friend who had COVID-19 (p < 0.001) used more plants for prevention. However, the respondents with technical or higher education used less plants for treatment (p < 0.001). Conclusion: There was a significant use of medicinal plants for both prevention and treatment, which was associated with several population characteristics and whether respondents had COVID-19.

CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 30, 2021. ; adjuvant for the treatment or prevention of respiratory symptoms during the COVID-19 pandemic in Cusco, Peru.

The survey was approved by the San Antonio Abad del Cusco National University ethics committee (#007-2020-CBI-UNSAAC). The participants remained anonymous and had the option to finish the survey at any time, and their information was kept confidential. All the survey participants were well-versed on the study intentions and were required to consent before the enrollment. The participants were not involved in any of the planning, execution and reporting stages of the study.

We conducted an online cross-sectional multicenter survey, which was initially evaluated by 10 expert judges using Aiken's V (40). After including the experts' observations, a pilot study was performed (from August 16 to 4) with 336 respondents in in five districts of Cusco, Peru. The pilot data was used to calculate the minimal sample size necessary for the actual study. It was determined that a minimum sample size of 1,530 was necessary to achieve a minimum percentage difference of 2.5% (49.0% versus 51.5%), a statistical power of 80%, and a confidence level of 95% (data not shown). The sample size was calculated using power analysis (41).

The actual survey consisted of an online questionnaire that was sent via WhatsApp, Messenger, and Facebook. The shared questionnaire was made anonymous ensuring data confidentiality and reliability. The survey was performed from August 31 to September 20, 2020 after approximately 9 months of lockdown and social distancing measures in Peru due to the COVID-19 outbreak. At the beginning of the survey (August 31) the number of COVID-19 confirmed cases was 652,037 and 28,944 deaths (42), while at the end of the survey (September 20) the confirmed cases . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 30, 2021. ; increased to 772,896 and the deaths increased to 31,474 (43). We surveyed general public who were adults of both genders aged 20 to 70 years in five districts of Cusco, Peru with high-risk COVID-19 transmission according to the Epidemiological Alert AE-017-2020 (44). The five districts were Cusco, San Jerónimo, San Sebastián, Santiago, and Wanchaq. Participants were recruited by the research team of the Universidad Nacional de San Antonio Abad del Cusco.

The survey (Annex 1) included 11 questions, 5 were demographic questions, 2 were related to the use of medicinal plants as preventive or treatment of respiratory symptoms related to COVID-19, 2 were related to the diagnosis of COVID-19 in themselves and the close environment (family and friends), and the last 2 questions related to the medicinal plants were used and to what respiratory symptom(s) they were used for. The demographic questions included sex, age, education level, occupation or professional activity and the district of residence in Cusco.

The respondents were asked to indicate if during the COVID-19 lockdown they used medicinal plants to prevent or treat respiratory symptoms related to COVID-19.

Then, the respondents were asked if they were diagnosed with COVID-19, and if any family member or friend was diagnosed with COVID-19. The respondents were asked to select from a list of 17 selected medicinal plants the ones they have used to prevent or treat COVID-19 related respiratory symptoms. Finally, the respondents were asked to select the symptom(s) why they consumed any of the medicinal plants indicated on the previous question. The symptoms included cough, sore throat, fever, headache or malaise. Loss of taste or smell, nausea/vomiting and diarrhea were not included. The selected symptoms relate to the most common COVID-19 symptoms reported by the Center of Disease Control and Prevention (CDC) (45).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 30, 2021. ; Data analysis was done in STATA version 14 (Stata Corp) with a significance level set at p<0.05. Descriptive analysis of categorical (demographic) variables was performed to show the frequency and percentage of each response. The results were summarized in unidimensional tables to identify the medicinal plants that are most used by the respondents. Chi-square test was performed in the bivariate analysis to determine the association between the studied variables. Generalized linear models were used in the multivariate analysis using the Poisson family, the log-link function, and the models for variances of robust models and the district of residence as a cluster, thereby obtaining the prevalence ratios (PR). The 95% confidence intervals (CI) and p-value < 0.05 were considered as the limit of statistical significance.

A total of 1,747 respondents participated in this study. The majority of the study participants were female [59.1% (1,033)], the median age was 31 years (interquartile range: 24-41 years), 29.7% (518) were university and high school students, 59.2%

(1,035) had higher education, and 33.3% (582) lived in the district of Cusco.

Concerning to the COVID-19 questions and use of medicinal plants, 12 Table 1) .

As shown on Table 2 , the use of medicinal plants for the prevention of respiratory symptoms was associated with gender (p < 0.001), age (p < 0.001), occupation (p < 0.001), education (p < 0.001), and whether a family member or friend had COVID-19 (p < 0.001). However, no association was observed with the district of residence (p = .

CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 30, 2021. ; 0.702) and if the respondent had COVID-19 (p = 0.632). In the case of the use of medicinal plants for the treatment of respiratory symptoms, the bivariate analysis showed that it was associated with gender (p = 0.013), age (p < 0.001), occupation (p < 0.001), education (p < 0.001), district of residence (p = 0.005), whether the respondent had COVID-19 (p < 0.001), and whether a family member or friend had COVID-19 (p < 0.001). Therefore, it could be observed that in general the respondents preferably used medicinal plants as treatment of respiratory symptoms.

As shown on Table 3 , the respondents mentioned the use of 17 medicinal plants for the treatment of COVID-19 related respiratory symptoms. The most frequently used medicinal plant was eucalyptus followed by ginger, garlic, spiked pepper, chamomile and coca. It was observed that all the medicinal plants were used for 2 or more respiratory symptoms. The bivariate statistics showed that the use of medicinal plants was associated with the occurrence of two or more symptoms (24-51%), followed by malaise (11-41%). In addition, there was a difference in consumption according to the type of symptom (p < 0.041) for all medicinal plants except panty (p = 0.076).

In the multivariate analysis (Table 4) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 30, 2021. ; prevention only (PR: 1.06, 95% CI: 1.01-1.11, p = 0.023), and the use of chamomile for treatment only (PR: 1.12, 95% CI: 1.03-1.23, p = 0.011).

There was also a negative association between the use of wira wira for treatment (PR: 0.9, 95% CI: 0.82-0.98, p = 0.016) and prevention (PR: 0.89, 95% CI: 0.85-0.93, p < 0.001) and the use of panty for treatment only (PR: 0.87, 95% CI: 0.78-0.97, p = 0.009). Therefore, eucalyptus, spiked pepper, ginger, and chamomile were the most used for the treatment of respiratory symptoms, whereas panty and wira wira were the least used. As for prevention, eucalyptus, spiked pepper, ginger, and garlic were the most used, whereas wira wira was the least used.

Regarding the adjustment of demographic variables and the use of medicinal plants for the treatment or prevention of respiratory symptoms, it is important to mention that there was a positive association between age and prevention (PR: 1.00, 95% CI: 1.00-1.01, p = 0.046). Precisely, older respondents used more medicinal plants for prevention. There was also a positive association between the respondents diagnosed with COVID-19 and the use of medicinal plants for treatment (PR: 1.22, 95% CI: 1.11-1.34, p < 0.001); precisely, those with COVID-19 used more medicinal plants for prevention. There was also a positive association between the respondents with a family member or friend diagnosed with COVID-19 and the use of medicinal plants for treatment (PR: 1.11, 95% CI: 1.06-1.17, p < 0.001) and prevention (PR: 1.08, 95% CI:

1.04-1.13, p < 0.001), but the respondents used fewer plants for treatment if they had a technical or higher education (PR: 0.89, 95% CI: 0.83-0.95, p < 0.001).

Regarding the prevention of COVID-19 respiratory symptoms, this study showed that 80.2% of the population of Cusco, Peru, used medicinal plants for this purpose.

Comparatively, a study conducted in a population of the state of Querétaro in Mexico showed that the main conditions treated with medicinal plants were asthma (18.42%), bronchitis (2.6%), flu (5.2%), congestion in the respiratory tract (10.5%), sore throat . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 30, 2021. ;

(21%), throat infection (15.7%), pneumonia (5.2%), sinusitis (10.55%), cough (55.2%), and tuberculosis (2.6%) (46) . Additionally, there are populations in many regions of the world that are using medicinal plants for the prevention of COVID-19, because these plants are more readily available than Western medicine. In this regard, a study performed in the Moroccan population has mentioned medicinal plants similar to those reported in this study, such as eucalyptus, garlic, onion, ginger, thyme, turmeric, and rosemary (47) .

Regarding the use of medicinal plants for the treatment of COVID-19 respiratory symptoms, 29.0% of the respondents did not use any plant, whereas 71.0% did. One of the most relevant clinical manifestations of COVID-19 is the great damage on the respiratory tract, causing respiratory distress that can lead to death, and for this reason, effective and non-invasive treatments are required (48) . This includes the use of medicinal plants, which were revalued during this pandemic to manage the COVID-19 symptoms, because plants are a source of plant metabolites with antiviral activity (49) . In this context, a study carried out in Bolivia evaluated eucalyptus, wira wira, and chamomile for their antibacterial, anti-inflammatory, and fungicidal properties (23).

Alternatively, it has been reported that diet supplementation with probiotics and nutraceuticals play a fundamental role in the treatment of respiratory symptoms, because many products produce an immune response to respiratory viruses in addition to their regulatory activity for the inflammation caused by COVID-19 (50) . The therapeutic use of medicinal plants has increased in many Latin American countries over time (51) . Our study reported that 80% of the respondents used medicinal plants when they or their family member or friend had COVID-19, which correlates to previous reports (52) .

As for the socio-educational factors associated with the use of medicinal plants for the prevention of respiratory symptoms, our study reported that female respondents (83.1%) used them. This correlates to previous studies where women are more versed in the properties of medicinal plants (53) and that they typically use medicinal plants to . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 30, 2021. ; take care of the health of their family members (54, 55) . Therefore, probably in most populations, women are those who transmit the traditional domestic knowledge from generation to generation (56) . For the treatment of COVID-19 respiratory symptoms, 24 to 51% of respondents in our study used medicinal plants when there were more than two symptoms and 11 to 41% when they presented malaise. There are studies describing the ethnomedicinal use during the COVID-19 pandemic of different communities and cultures around the world, especially in Asian countries, such as India, China, Japan, and Pakistan and some parts of Africa (61) . COVID-19 symptoms develop with inflammation and hemotoxicity, which could suggest that blood-purifying plants with anti-inflammatory, antioxidant, and antiviral properties could be considered as candidates for the treatment of COVID-19 (62) . There are also herbal remedies, such as those made from Uncaria tomentosa or cat's claw, a climbing vine that grows in the Peruvian jungle, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 30, 2021.

which is used to stimulate the immune system (61) . The most used plants in our study included eucalyptus, turmeric, garlic, lemon balm, and geranium. It has been reported that eucalyptus is an effective antiviral agent against SARS-CoV-2 for its eucalyptol content, which was assessed in molecular docking studies (61) . Moreover, it has been reported that jensenone, a compound obtained from the essential oil of eucalyptus exhibits antiviral effect against the main protein of SARS-CoV-2 (61). Additionally, garlic exhibited an inhibitory effect on SARS-CoV-2 replication; thus, it is a promising agent against COVID-19 (63). A similar effect was found for palillo, a curcumin extracted from turmeric (63), as determined by molecular docking studies (61) . A metaanalysis study performed on medicinal plants suggested that plants, such as turmeric, can be used as a prophylaxis against SARS-CoV-2 according to docking studies that suggest its use; therefore, more trials should be carried out (62) . Another study was performed on natural molecules from plants with antiviral properties such as rosemary and cinnamon, reporting that they present low toxicity, and abundant active ingredients is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 30, 2021. ; or treatment of respiratory symptoms related to COVID-19 still needs to be evaluated in clinical settings in order to have solid evidence of their effectiveness and to isolate compounds with potential pharmacological use.

The limitations of this study included the fact that the results cannot be extrapolated to the entire Peruvian population. The objective of this study was to determine the association between the use of medicinal plants and the treatment or prevention of respiratory symptoms in the population of the five districts of Cusco, one of the most important cities in Peru. However, this study is the first to investigate this association in this population; therefore, this could become a basis for other studies that could cover a larger population from all over the country.

Another limitation is bias occurred as a result of the cross-sectional study design to determine definitive cause and effect associations. Similarly, the responders performed a self-reported assessment in an online data collection platform, which could lead to under or over-reporting and the data collector has not ability to verify or validate.

The current study reported an association between the use of medicinal plants and the treatment or prevention of the respiratory symptoms related to COVID-19, and the most used plants were eucalyptus, ginger, chamomile, and garlic. Moreover, it was determined that the study population used a greater number of plants for disease prevention when the respondent was older and if they or a friend or family member had contracted COVID-19.

None . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 30, 2021. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 30, 2021. ; is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 30, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 30, 2021. ; https://doi.org/10.1101/2021.05.26.21257890 doi: medRxiv preprint

Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 11

Percepción de las medidas de salud pública en Perú para frenar el avance de la COVID-19

Anxiety, Distress, and Turnover Intention of Healthcare Workers in Peru by Their Distance to the Epicenter during the COVID-19 Crisis

Hospitality Workers' COVID-19 Risk Perception and Depression: A Contingent Model Based on Transactional Theory of Stress Model

Opportunity for eHealth due to COVID-19 Outbreak: Case of Peru

Demographic and Geographic COVID-19 Death Risk Factors in Peru

Rapid Response: Does Peru really have that high number of COVID-19 confirmed cases? The deception of combining RT-PCR and rapid test results: The British Medical Journal

Clearing the path for COVID-19 in Peru? The decision of supervised walks for children and . CC-BY-NC-ND 4.0 International license It is made available under a 45. CDC. Coronavirus Disease 2019 Symptoms: Center for Disease Control and Prevention

Plantas para afecciones respiratorias comercializadas en tres mercados de la ciudad de Santiago de Querétaro

Medicinal plants used for the prevention purposes during the Covid-19 pandemic in Morocco

A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants

Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic

Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review

Las Plantas Medicinales y su aplicación en la Salud Pública

Cold plants" and "Hot plants" potential resources in the prevention and / or treatment of COVID-19

Los aportes de las mujeres rurales al conocimiento de plantas medicinales en México: Análisis de género. Agricultura, sociedad y desarrollo

Uso y conocimiento de plantas medicinales por hombres y mujeres en dos . CC-BY-NC-ND 4.0 International license It is made available under a localidades indígenas en Coyomeapan

Criterios que inciden en la identificación y uso de las plantas de interés para el turismo en Jipijapa

De enfermedades y remedios: la transmisión oral del uso doméstico de plantas con fines medicinales en Campeche

Medicinal Plants and Primary Health Care: The Role of Gender

Health seeking behavior and use of medicinal plants among the Hamer ethnic group, South Omo zone, southwestern Ethiopia

Food security and women's roles in Moroccan Berber (Amazigh) society today. Maternal & Child Nutrition

Influence of the use of medicinal plants in medication adherence in elderly people

Potentials of plant-based substance to inhabit and probable cure for the COVID-19

Phytotherapeutic Evidence Against Coronaviruses and Prospects for COVID-19

A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complementary therapies in clinical practice

The authors would like to acknowledge the Universidad Nacional de San Antonio Abad del Cusco (UNSAAC) for providing the necessary materials for this study.